Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 700 shares, a drop of 41.7% from the November 30th total of 1,200 shares. Based on an average daily volume of 7,500 shares, the short-interest ratio is presently 0.1 days.

Relief Therapeutics Stock Up 4.2 %

Shares of OTCMKTS:RLFTF opened at $4.70 on Friday. Relief Therapeutics has a 1 year low of $1.10 and a 1 year high of $7.66. The stock’s fifty day moving average price is $5.73 and its 200-day moving average price is $3.35.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.